Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Nakul Katyal"'
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
PurposeTo describe the early experience of ravulizumab use in acetylcholine receptor antibody-positive generalized myasthenia gravis (AChR+ve gMG).MethodsThis multicenter retrospective study included AChR+ve gMG patients who were treated with ravuliz
Externí odkaz:
https://doaj.org/article/d2676b2195924eeea1677199cb829f5d
Publikováno v:
International Journal of Telemedicine and Applications, Vol 2022 (2022)
The declaration of the COVID-19 pandemic necessitated rapid implementation of telehealth across all neurological subspecialties. Transitioning to telehealth technology can be challenging for physicians and health care facilities with no prior experie
Externí odkaz:
https://doaj.org/article/8a665378d8364522bbaa91cc67fc2192
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Introduction: Diagnosis of Guillain Barre syndrome (GBS) is often made clinically. Certain patient and disease characteristics can cause delays in diagnosis and management.Methods: Observational retrospective study of forty-four patients diagnosed wi
Externí odkaz:
https://doaj.org/article/fc8ce511e701469490e194ab52e6f4bd
Lateralized periodic discharges are predictive of seizures in patients with intracerebral hemorrhage
Publikováno v:
Annals of Indian Academy of Neurology, Vol 22, Iss 4, Pp 414-418 (2019)
Background: Patients with intracerebral hemorrhages (ICHs) have higher incidence of seizures. Previous studies have suggested that location and size of hemorrhage may increase epileptogenicity. We aim to evaluate seizure development risk factors from
Externí odkaz:
https://doaj.org/article/68a2a3d1e6244ba3bd260ae8cb67c880
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Objective: To report the case of a 35-year-old woman with treatment-resistant aquaporin-4 (AQP-4) immunoglobulin G (IgG) seronegative neuromyelitis optica spectrum disorder (NMOSD) successfully treated with eculizumab (a terminal complement inhibitor
Externí odkaz:
https://doaj.org/article/174adad1108b4edbbdcb9b048f95c52b
Autor:
Naureen Narula, Nakul Katyal, Mohammed Salem, Akshay Avula, Abdulhassan Siddiqui, Rabih Maroun, Michel Chalhoub
Publikováno v:
Respiratory Medicine Case Reports, Vol 34, Iss , Pp 101420- (2021)
Indwelling Pleural Catheters (IPC) are increasingly being used for management of recurrent pleural effusions (RPEs). Use of IPC for management of both malignant and non-malignant recurrent pleural effusions has been associated with complications such
Externí odkaz:
https://doaj.org/article/5ffd9bc535e749d087b2515816a49396
Publikováno v:
Case Reports in Neurological Medicine, Vol 2021 (2021)
Patients receiving complement inhibitor, eculizumab, are at high risk for infections with encapsulated organisms such as Neisseria due to impaired opsonophagocytic activity. Impaired complement immunity may increase the risk for dissemination of asym
Externí odkaz:
https://doaj.org/article/dbebe57cbac14aa4997618f958ed2720
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases were first reported in Wuhan, Hubei province of China in December, 2019. SARS- COV-2 primarily affects the cardio-respiratory system. Over the last few months, several studies have de
Externí odkaz:
https://doaj.org/article/f59da522cb67456e9c74a8da2dd34d5c
Autor:
Sushma Yerram, Nakul Katyal, Keerthivaas Premkumar, Premkumar Nattanmai, Christopher R. Newey
Publikováno v:
Journal of Intensive Care, Vol 6, Iss 1, Pp 1-10 (2018)
Abstract Background Seizures are a considerable complication in critically ill patients. Their incidence is significantly high in neurosciences intensive care unit patients. Seizure prophylaxis with anti-epileptic drugs is a common practice in neuros
Externí odkaz:
https://doaj.org/article/1742dfedf31f4b19bfc724699193739a
Autor:
Nakul Katyal, Raghav Govindarajan
Publikováno v:
Frontiers in Neurology, Vol 8 (2017)
Amyotrophic lateral sclerosis (ALS) is a clinically progressive neurodegenerative syndrome predominantly affecting motor neurons and their associated tracts. Riluzole and edaravone are the only FDA certified drugs for treating ALS. Over the past two
Externí odkaz:
https://doaj.org/article/7451d8b4de574f72a0ef951d5313b05e